NCT00296894View on ClinicalTrials.gov

Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Erosive Osteo-Arthritis
Interventions
DRUG

Adalimumab (40 mg sc every other week)

Adalimumab (40 mg sc every other week)

DRUG

Placebo

Placebo

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT00296894 - Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints | Biotech Hunter | Biotech Hunter